Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions
- Autores
- Liu, Grace; Segrè, Joel; Gülmezoglu, A Metin; Mathai, Matthews; Smith, Jeffrey M; Hermida, Jorge; Simen Kapeu, Aline; Barker, Pierre; Jere, Mercy; Moses, Edward; Moxon, Sarah G.; Dickson, Kim E.; Lawn, Joy E.; Althabe, Fernando
- Año de publicación
- 2015
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- BACKGROUND:Preterm birth complications are the leading cause of deaths for children under five years. Antenatal corticosteroids (ACS) are effective at reducing mortality and serious morbidity amongst infants born at <34 weeks gestation. WHO guidelines strongly recommend use of ACS for women at risk of imminent preterm birth where gestational age, imminent preterm birth, and risk of maternal infection can be assessed, and appropriate maternal/newborn care provided. However, coverage remains low in high-burden countries for reasons not previously systematically investigated.METHODS:The bottleneck analysis tool was applied in 12 countries in Africa and Asia as part of the Every Newborn Action Plan process. Country workshops involved technical experts to complete the survey tool, which is designed to synthesise and grade health system "bottlenecks", factors that hinder the scale up, of maternal-newborn intervention packages. We used quantitative and qualitative methods to analyse the bottleneck data, combined with literature review, to present priority bottlenecks and actions relevant to different health system building blocks for ACS.RESULTS:Eleven out of twelve countries provided data in response to the ACS questionnaire. Health system building blocks most frequently reported as having significant or very major bottlenecks were health information systems (11 countries), essential medical products and technologies (9 out of 11 countries) and health service delivery (9 out of 11 countries). Bottlenecks included absence of coverage data, poor gestational age metrics, lack of national essential medicines listing, discrepancies between prescribing authority and provider cadres managing care, delays due to referral, and lack of supervision, mentoring and quality improvement systems.CONCLUSIONS:Analysis centred on health system building blocks in which 9 or more countries (>75%) reported very major or significant bottlenecks. Health information systems should include improved gestational age assessment and track ACS coverage, use and outcomes. Better health service delivery requires clarified policy assigning roles by level of care and cadre of provider, dependent on capability to assess gestational age and risk of preterm birth, and the implementation of guidelines with adequate supervision, mentoring and quality improvement systems, including audit and feedback. National essential medicines lists should include dexamethasone for antenatal use, and dexamethasone should be integrated into supply logistics.
Fil: Liu, Grace. United Nations Commodities Commission. Antenatal Corticosteroids Working Group; Estados Unidos
Fil: Segrè, Joel. United Nations Commodities Commission. Antenatal Corticosteroids Working Group; Estados Unidos
Fil: Gülmezoglu, A Metin. World Health Organization. Special Programme of Research, Development and Research Training in Human Reproduction ; Suiza
Fil: Mathai, Matthews. Health Organization. Department of Maternal, Newborn, Child & Adolescent Health; Suiza
Fil: Smith, Jeffrey M. Jhpiego; Estados Unidos
Fil: Hermida, Jorge. University Research Co.; Estados Unidos
Fil: Simen Kapeu, Aline. Organización de Las Naciones Unidas. Unicef; Argentina
Fil: Barker, Pierre. Institute for Healthcare Improvement; Estados Unidos
Fil: Jere, Mercy. MaiKhanda Trust; Malaui
Fil: Moses, Edward. MaiKhanda Trust; Malaui
Fil: Moxon, Sarah G.. Maternal, Adolescent, Reproductive and Child Health Centre; Reino Unido
Fil: Dickson, Kim E.. Organización de Las Naciones Unidas. Unicef; Argentina
Fil: Lawn, Joy E.. Maternal, Adolescent, Reproductive and Child Health Centre; Reino Unido
Fil: Althabe, Fernando. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina - Materia
- Antenatal corticosteroids
- Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/47397
Ver los metadatos del registro completo
id |
CONICETDig_bbd6ba9d08633ee0feb9cb967bee0801 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/47397 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutionsLiu, GraceSegrè, JoelGülmezoglu, A MetinMathai, MatthewsSmith, Jeffrey MHermida, JorgeSimen Kapeu, AlineBarker, PierreJere, MercyMoses, EdwardMoxon, Sarah G.Dickson, Kim E.Lawn, Joy E.Althabe, FernandoAntenatal corticosteroidshttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3BACKGROUND:Preterm birth complications are the leading cause of deaths for children under five years. Antenatal corticosteroids (ACS) are effective at reducing mortality and serious morbidity amongst infants born at <34 weeks gestation. WHO guidelines strongly recommend use of ACS for women at risk of imminent preterm birth where gestational age, imminent preterm birth, and risk of maternal infection can be assessed, and appropriate maternal/newborn care provided. However, coverage remains low in high-burden countries for reasons not previously systematically investigated.METHODS:The bottleneck analysis tool was applied in 12 countries in Africa and Asia as part of the Every Newborn Action Plan process. Country workshops involved technical experts to complete the survey tool, which is designed to synthesise and grade health system "bottlenecks", factors that hinder the scale up, of maternal-newborn intervention packages. We used quantitative and qualitative methods to analyse the bottleneck data, combined with literature review, to present priority bottlenecks and actions relevant to different health system building blocks for ACS.RESULTS:Eleven out of twelve countries provided data in response to the ACS questionnaire. Health system building blocks most frequently reported as having significant or very major bottlenecks were health information systems (11 countries), essential medical products and technologies (9 out of 11 countries) and health service delivery (9 out of 11 countries). Bottlenecks included absence of coverage data, poor gestational age metrics, lack of national essential medicines listing, discrepancies between prescribing authority and provider cadres managing care, delays due to referral, and lack of supervision, mentoring and quality improvement systems.CONCLUSIONS:Analysis centred on health system building blocks in which 9 or more countries (>75%) reported very major or significant bottlenecks. Health information systems should include improved gestational age assessment and track ACS coverage, use and outcomes. Better health service delivery requires clarified policy assigning roles by level of care and cadre of provider, dependent on capability to assess gestational age and risk of preterm birth, and the implementation of guidelines with adequate supervision, mentoring and quality improvement systems, including audit and feedback. National essential medicines lists should include dexamethasone for antenatal use, and dexamethasone should be integrated into supply logistics.Fil: Liu, Grace. United Nations Commodities Commission. Antenatal Corticosteroids Working Group; Estados UnidosFil: Segrè, Joel. United Nations Commodities Commission. Antenatal Corticosteroids Working Group; Estados UnidosFil: Gülmezoglu, A Metin. World Health Organization. Special Programme of Research, Development and Research Training in Human Reproduction ; SuizaFil: Mathai, Matthews. Health Organization. Department of Maternal, Newborn, Child & Adolescent Health; SuizaFil: Smith, Jeffrey M. Jhpiego; Estados UnidosFil: Hermida, Jorge. University Research Co.; Estados UnidosFil: Simen Kapeu, Aline. Organización de Las Naciones Unidas. Unicef; ArgentinaFil: Barker, Pierre. Institute for Healthcare Improvement; Estados UnidosFil: Jere, Mercy. MaiKhanda Trust; MalauiFil: Moses, Edward. MaiKhanda Trust; MalauiFil: Moxon, Sarah G.. Maternal, Adolescent, Reproductive and Child Health Centre; Reino UnidoFil: Dickson, Kim E.. Organización de Las Naciones Unidas. Unicef; ArgentinaFil: Lawn, Joy E.. Maternal, Adolescent, Reproductive and Child Health Centre; Reino UnidoFil: Althabe, Fernando. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaBioMed Central2015-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfhttp://hdl.handle.net/11336/47397Liu, Grace; Segrè, Joel; Gülmezoglu, A Metin; Mathai, Matthews; Smith, Jeffrey M; et al.; Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions; BioMed Central; BMC Pregnancy and Childbirth; 15; S2; 9-2015; 1-161741-7015CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1186/1471-2393-15-S2-S3info:eu-repo/semantics/altIdentifier/url/https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/1471-2393-15-S2-S3info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-15T14:47:55Zoai:ri.conicet.gov.ar:11336/47397instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-15 14:47:55.428CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions |
title |
Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions |
spellingShingle |
Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions Liu, Grace Antenatal corticosteroids |
title_short |
Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions |
title_full |
Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions |
title_fullStr |
Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions |
title_full_unstemmed |
Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions |
title_sort |
Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions |
dc.creator.none.fl_str_mv |
Liu, Grace Segrè, Joel Gülmezoglu, A Metin Mathai, Matthews Smith, Jeffrey M Hermida, Jorge Simen Kapeu, Aline Barker, Pierre Jere, Mercy Moses, Edward Moxon, Sarah G. Dickson, Kim E. Lawn, Joy E. Althabe, Fernando |
author |
Liu, Grace |
author_facet |
Liu, Grace Segrè, Joel Gülmezoglu, A Metin Mathai, Matthews Smith, Jeffrey M Hermida, Jorge Simen Kapeu, Aline Barker, Pierre Jere, Mercy Moses, Edward Moxon, Sarah G. Dickson, Kim E. Lawn, Joy E. Althabe, Fernando |
author_role |
author |
author2 |
Segrè, Joel Gülmezoglu, A Metin Mathai, Matthews Smith, Jeffrey M Hermida, Jorge Simen Kapeu, Aline Barker, Pierre Jere, Mercy Moses, Edward Moxon, Sarah G. Dickson, Kim E. Lawn, Joy E. Althabe, Fernando |
author2_role |
author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
Antenatal corticosteroids |
topic |
Antenatal corticosteroids |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
BACKGROUND:Preterm birth complications are the leading cause of deaths for children under five years. Antenatal corticosteroids (ACS) are effective at reducing mortality and serious morbidity amongst infants born at <34 weeks gestation. WHO guidelines strongly recommend use of ACS for women at risk of imminent preterm birth where gestational age, imminent preterm birth, and risk of maternal infection can be assessed, and appropriate maternal/newborn care provided. However, coverage remains low in high-burden countries for reasons not previously systematically investigated.METHODS:The bottleneck analysis tool was applied in 12 countries in Africa and Asia as part of the Every Newborn Action Plan process. Country workshops involved technical experts to complete the survey tool, which is designed to synthesise and grade health system "bottlenecks", factors that hinder the scale up, of maternal-newborn intervention packages. We used quantitative and qualitative methods to analyse the bottleneck data, combined with literature review, to present priority bottlenecks and actions relevant to different health system building blocks for ACS.RESULTS:Eleven out of twelve countries provided data in response to the ACS questionnaire. Health system building blocks most frequently reported as having significant or very major bottlenecks were health information systems (11 countries), essential medical products and technologies (9 out of 11 countries) and health service delivery (9 out of 11 countries). Bottlenecks included absence of coverage data, poor gestational age metrics, lack of national essential medicines listing, discrepancies between prescribing authority and provider cadres managing care, delays due to referral, and lack of supervision, mentoring and quality improvement systems.CONCLUSIONS:Analysis centred on health system building blocks in which 9 or more countries (>75%) reported very major or significant bottlenecks. Health information systems should include improved gestational age assessment and track ACS coverage, use and outcomes. Better health service delivery requires clarified policy assigning roles by level of care and cadre of provider, dependent on capability to assess gestational age and risk of preterm birth, and the implementation of guidelines with adequate supervision, mentoring and quality improvement systems, including audit and feedback. National essential medicines lists should include dexamethasone for antenatal use, and dexamethasone should be integrated into supply logistics. Fil: Liu, Grace. United Nations Commodities Commission. Antenatal Corticosteroids Working Group; Estados Unidos Fil: Segrè, Joel. United Nations Commodities Commission. Antenatal Corticosteroids Working Group; Estados Unidos Fil: Gülmezoglu, A Metin. World Health Organization. Special Programme of Research, Development and Research Training in Human Reproduction ; Suiza Fil: Mathai, Matthews. Health Organization. Department of Maternal, Newborn, Child & Adolescent Health; Suiza Fil: Smith, Jeffrey M. Jhpiego; Estados Unidos Fil: Hermida, Jorge. University Research Co.; Estados Unidos Fil: Simen Kapeu, Aline. Organización de Las Naciones Unidas. Unicef; Argentina Fil: Barker, Pierre. Institute for Healthcare Improvement; Estados Unidos Fil: Jere, Mercy. MaiKhanda Trust; Malaui Fil: Moses, Edward. MaiKhanda Trust; Malaui Fil: Moxon, Sarah G.. Maternal, Adolescent, Reproductive and Child Health Centre; Reino Unido Fil: Dickson, Kim E.. Organización de Las Naciones Unidas. Unicef; Argentina Fil: Lawn, Joy E.. Maternal, Adolescent, Reproductive and Child Health Centre; Reino Unido Fil: Althabe, Fernando. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina |
description |
BACKGROUND:Preterm birth complications are the leading cause of deaths for children under five years. Antenatal corticosteroids (ACS) are effective at reducing mortality and serious morbidity amongst infants born at <34 weeks gestation. WHO guidelines strongly recommend use of ACS for women at risk of imminent preterm birth where gestational age, imminent preterm birth, and risk of maternal infection can be assessed, and appropriate maternal/newborn care provided. However, coverage remains low in high-burden countries for reasons not previously systematically investigated.METHODS:The bottleneck analysis tool was applied in 12 countries in Africa and Asia as part of the Every Newborn Action Plan process. Country workshops involved technical experts to complete the survey tool, which is designed to synthesise and grade health system "bottlenecks", factors that hinder the scale up, of maternal-newborn intervention packages. We used quantitative and qualitative methods to analyse the bottleneck data, combined with literature review, to present priority bottlenecks and actions relevant to different health system building blocks for ACS.RESULTS:Eleven out of twelve countries provided data in response to the ACS questionnaire. Health system building blocks most frequently reported as having significant or very major bottlenecks were health information systems (11 countries), essential medical products and technologies (9 out of 11 countries) and health service delivery (9 out of 11 countries). Bottlenecks included absence of coverage data, poor gestational age metrics, lack of national essential medicines listing, discrepancies between prescribing authority and provider cadres managing care, delays due to referral, and lack of supervision, mentoring and quality improvement systems.CONCLUSIONS:Analysis centred on health system building blocks in which 9 or more countries (>75%) reported very major or significant bottlenecks. Health information systems should include improved gestational age assessment and track ACS coverage, use and outcomes. Better health service delivery requires clarified policy assigning roles by level of care and cadre of provider, dependent on capability to assess gestational age and risk of preterm birth, and the implementation of guidelines with adequate supervision, mentoring and quality improvement systems, including audit and feedback. National essential medicines lists should include dexamethasone for antenatal use, and dexamethasone should be integrated into supply logistics. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-09 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/47397 Liu, Grace; Segrè, Joel; Gülmezoglu, A Metin; Mathai, Matthews; Smith, Jeffrey M; et al.; Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions; BioMed Central; BMC Pregnancy and Childbirth; 15; S2; 9-2015; 1-16 1741-7015 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/47397 |
identifier_str_mv |
Liu, Grace; Segrè, Joel; Gülmezoglu, A Metin; Mathai, Matthews; Smith, Jeffrey M; et al.; Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions; BioMed Central; BMC Pregnancy and Childbirth; 15; S2; 9-2015; 1-16 1741-7015 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1186/1471-2393-15-S2-S3 info:eu-repo/semantics/altIdentifier/url/https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/1471-2393-15-S2-S3 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/vnd.openxmlformats-officedocument.wordprocessingml.document application/pdf |
dc.publisher.none.fl_str_mv |
BioMed Central |
publisher.none.fl_str_mv |
BioMed Central |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1846082997364719616 |
score |
13.22299 |